“咳喘贴”伏九贴敷防治儿童哮喘的临床研究

发布时间：2018-06-10 18:12

本文选题：咳喘贴 + 伏九贴敷　；参考：《甘肃中医学院》2014年硕士论文

【摘要】：目的：本课题根据中医学“治未病”、运气学说等理论为指导，观察应用“咳喘贴”伏九贴敷结合中药汤剂疗法对儿童哮喘的症状、体征、发作次数、C-ACT得分、EOS计数的变化情况，总结本治法的临床疗效及应用特点，，为丰富中医学“治未病”的理论、广泛推广本疗法及进一步改进、提高本疗法疗效提供临床依据。方法：将72例儿童哮喘患者按就诊的先后顺序编号后随机分为2组：对照组和治疗组，每组36例。对照组急性期中医辨证论治，予以中药汤剂口服并按需选用西药控制，缓解期予以中药汤剂治疗；治疗组全部病例除上述基础治疗外，另予以咳喘贴穴位贴敷治疗，时间为每年夏季三伏期间，从初伏开始每十天贴敷1次，共3次；每年冬季三九期间，从一九开始每九天贴敷1次，共3次。每次分别贴敷于患儿双侧肺俞、心俞、膈俞及膻中穴位上。每次贴8-12小时（若有明显痛痒、起泡，可提前揭去）。加减穴：痰多、食欲欠佳者加脾俞；仅痰多者加丰隆。以上两组均观察治疗前后患儿证候积分、儿童哮喘控制测试（C-ACT）得分、EOS（嗜酸性粒细胞计数）等实验室指标，并记录治疗前后复发次数。结果： ①经连续两年治疗后，两种治疗方法对哮喘患者均有效，治疗组总有效率为88.9%，对照组总有效率为69%，两者具有统计学意义（P＜0.05）； ②两组经治疗均能改善哮喘患者喘息、咳嗽、呼吸音等症状及体征，然治疗组与对照组比较，治疗组优于对照组，具有统计学意义（P＜0.05）； ③在提高C-ACT得分、降低EOS计数及减少哮喘反复发作次数方面，同样治疗组优于对照组，具有统计学意义（P＜0.05）。结论：“咳喘贴”伏九贴敷结合中药汤剂综合治疗儿童哮喘，在防治儿童哮喘反复发作、改善患者临床症状、减轻炎症水平及提高生活质量等方面明显优于单纯运用中药汤剂疗法，且本研究过程中未见明显不良反应及毒副作用，体现了本综合治法对于儿童哮喘患者具有显著的临床疗效及良好的的社会效益，应广泛推广临床，造福哮喘患儿。
[Abstract]:Objective: to observe the changes of symptoms, signs, C-ACT scores and EOS count of children asthma treated by "Kechuantie" Fujiu application combined with traditional Chinese medicine decoction according to the theory of "cure before illness" and "luck theory" in traditional Chinese medicine. In order to enrich the theory of "cure without disease" in traditional Chinese medicine, the clinical curative effect and application characteristics of this method are summarized, and the therapy is widely popularized and further improved. Methods: 72 children with asthma were randomly divided into two groups: control group and treatment group with 36 cases in each group. In the control group, TCM was treated according to syndrome differentiation in the acute phase, oral Chinese medicine decoction was given and controlled by western medicine as needed, while in the remission period, the treatment group was treated with traditional Chinese medicine decoction. In addition to the above basic treatment, all the cases in the treatment group were treated with Kechuan plaster at the acupoint. The time is 3 times a year during summer three volts a year, every 10 days from the first volt, and 3 times every nine days in winter. Each time applied on the bilateral Fesu, Xinshu, Geshu and Shanzhong points. Each application 8-12 hours (if there is obvious pain and itch, bubble, can be removed in advance. Add and decrease points: phlegm more, appetite poor plus spleen Yu; only phlegm plus Fenglong. The syndrome scores, C-ACTs and eosinophil count were observed in the two groups before and after treatment. Results: 1 after two consecutive years of treatment, the number of recurrence was recorded, and the EOS (eosinophilic granulocyte count) scores were recorded before and after treatment. The total effective rate was 88.9 in the treatment group and 69 in the control group (P < 0.05). However, compared with the control group, the treatment group was superior to the control group (P < 0.05). 3 the treatment group was superior to the control group in increasing C-ACT score, decreasing EOS count and reducing the number of recurrent asthma attacks. Conclusion: "Kechuantie" Fujiu application combined with traditional Chinese medicine decoction in the comprehensive treatment of childhood asthma, in the prevention and treatment of children asthma recurrent attacks, improve the clinical symptoms of patients, In the aspects of reducing inflammation and improving quality of life, it was better than that of using traditional Chinese medicine decoction alone, and there were no obvious adverse reactions and side effects in the course of this study. This comprehensive treatment method has significant clinical efficacy and good social benefit for children with asthma, and should be widely popularized to benefit children with asthma.
【学位授予单位】：甘肃中医学院
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：R272

【相似文献】